Posted On: 11/20/2015 11:25:10 AM
Post# of 72443
Generic Name: thioureidobutyronitrile
Trade Name: Kevetrin
Date Designated: 11/17/2015
Orphan Designation: Treatment of retinoblastoma.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Sponsor: Cellceutix Corporation
100 Cummings Center
Suite 151-B
Beverly, Massachusetts 01915
The sponsor address listed is the last reported by the sponsor to OOPD.
Trade Name: Kevetrin
Date Designated: 11/17/2015
Orphan Designation: Treatment of retinoblastoma.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Sponsor: Cellceutix Corporation
100 Cummings Center
Suite 151-B
Beverly, Massachusetts 01915
The sponsor address listed is the last reported by the sponsor to OOPD.
(0)
(0)Scroll down for more posts ▼
